How significant is the role of patient satisfaction in determining cosentyx's market share versus humira?

How much does patient satisfaction shape Cosentyx's market share?

Patient satisfaction plays a moderate role in Cosentyx's market share decisions. Clinical efficacy and insurance coverage often outweigh satisfaction scores. Insurance formulary placement and physician preference remain stronger drivers than satisfaction ratings alone.

What patient feedback channels affect Cosentyx versus Humira?

Patients report fewer injection-site reactions with Cosentyx than with Humira. Cosentyx offers fewer injection frequencies—once monthly versus twice monthly for Humira. These factors improve adherence and boost satisfaction among patients who value convenience.

How does insurance coverage tilt the balance between Cosentyx and Humira?

Insurance coverage frequently determines access. Many plans require patients to fail first-line treatments before covering Cosentyx. Step therapy requirements and copay assistance programs influence which product patients ultimately receive.

When does Cosentyx lose exclusivity?

Cosentyx exclusivity expires in 2025. After that point, biosimilars may enter the market and compete directly with both Cosentyx and Humira.